Comment on: The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients. Is there a room for vitamin D?

References

1. ↵
   1. Sukkarieh HH,
   2. Bustami RT,
   3. Abdu MN,
   4. Khokhar AA,
   5. Salih AA,
   6. Abdalla HK

   (2020) The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients. Is there a room for vitamin D? Saudi Med J 41:1083–1089.

   OpenUrlAbstract/FREE Full Text
2. ↵
   1. World Health Organization. International Agency for Research on Cancer. Vitamin D and Cancer. IARC Working Group Reports

   , Updated 2008 November. 2020 October 12, Available from URL: http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk5/Report_VitD.pdf, 5.
3. 1. Rosen CJ,
   2. Adams JS,
   3. Bikle DD,
   4. Black DM,
   5. Demay MB,
   6. Manson JE,
   7. et al.

   (2012) The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev 33:456–492.

   OpenUrlCrossRefPubMedWeb of Science
4. 1. Kupferschmidt K

   (2012) Uncertain verdict as vitamin D goes on trial. Science 337:1476–1478.

   OpenUrlAbstract/FREE Full Text
5. ↵
   1. Bouillon R,
   2. Marcocci C,
   3. Carmeliet G,
   4. Bikle D,
   5. White JH,
   6. Dawson-Hughes B,
   7. et al.

   (2019) Skeletal and extraskeletal actions of vitamin d: current evidence and outstanding questions. Endocr Rev 40:1109–1551.

   OpenUrlPubMed
6. ↵
   1. Scientific Advisory Committee on Nutirion (SACN)

   (2016) Vitamin D and Health, Updated 2016 July, Available from URL: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/537616/SACN_Vitamin_D_and_Health_report.pdf. Accessed 2020 October 16.